CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Sandwell & West Birmingham NHS Trust

Clare Nash, Head of Clinical Procurement

Role of Clinical Procurement for Healthcare's Resilient Future

Clare Nash

Clare Nash

Clinical Procurement Authority

Clare Nash is Head of Clinical Products Management for the Black Country Alliance covering Sandwell and West Birmingham NHS Trust and The Dudley Group of Hospitals NHS Foundation Trust. She is an expert in the field of sustainable procurement in the National Health Service (NHS) in England and has authored several papers including “It’s not easy being green – a tool for choosing sustainable clinical products” and most recently “Reusable tourniquets: their impact on patients, planet and public purse.” She is an international speaker focusing on how clinical staff can contribute towards net zero and a greener healthcare system.


Through this article Nash highlights the importance of resilience, collaboration and sustainability to drive change in clinical procurement.


Building Resilience in Healthcare Supply Chains                           


Since Covid-19 and subsequently the impact Brexit has had on importing of goods, clinical procurement has been an extremely challenging role. Internationally, the lack of resilience of supply (PPE, as well as thousands of other product lines) has led us to look to new ways of working. This has presented us with opportunities that have brought our profession closer together and spotlighted the incredible resource our colleagues bring to the collective healthcare table.


We now have a robust system of mutual aid in place when supplies are impacted. We share products between organisations and across regions or we can offer alternatives to the current product lines based on our clinical experiences, without compromising on patient safety.


Procuring reusable clinical products to last, rather than having to constantly replenish single-use items, will ensure the stock is always there. When we have a circular economy, we are no longer reliant on shipping containers arriving on time or the transporting of goods through war-torn regions or depleting the planet of its natural resources.


Embracing Collective Expertise


I have built up a strong network and alliance of many clinical, managerial and external stakeholders over the years of working for the NHS. Implementing change means ensuring you are open and transparent and are collaborative in your approach. Acknowledging I may not be the expert in the room, but opening the floor for others to contribute ensures you take your stakeholders with you on the journey. Finding the why (thank you Simon Sinek!) for each stakeholder is also a vital step.


Procurement to Drive Change


Procurement staff are the collaborators and front-line enablers of the process of getting products to the patient care setting. Without interdisciplinary collaboration, there can be no decisions made. Setting up strong governance processes approved at board level or C-suite is essential in supporting clinically safe, sustainable and financially robust procurement. Without this, we would just become a team that processes orders, task oriented, back office.


"Setting up strong governance processes approved at board level or C-suite is essential in supporting clinically safe, sustainable and financially robust procurement. Without this, we would just become a team that processes orders, task oriented, back office"


The biggest challenge we now face is undoubtedly the climate emergency. The slower we are to respond globally, the more our populations are getting sicker as a result. Polluted air, water, seas, increasing temperatures, wildfires, drought, hurricanes and floods are all impacting on the health of those living in affected regions, as well as this impacting on the manufacturing of products we need to deliver care.


We know that about 62% of the NHS carbon footprint comes from our supply chains so it’s absolutely in our clinical procurement and collective nursing gift to influence and reduce this. If we can procure locally, from suppliers who are genuinely committed to reducing their carbon emissions and net zero targets and we move back to reuse where safe to do so, we can begin to tackle the growing threats of global logistics challenges.


We cannot do this alone though; strengthening the decontamination facilities, investing in research and innovation and procuring for patient outcomes and climate mitigation and adaptation, not for savings are all critical pieces of the jigsaw.


Key Advice for Aspiring Leaders


I have spent all of my career in the NHS. I believe it’s not what you know (although clearly important!) it is WHO that makes the difference. Keeping your relationships and networks close is the key to getting things done. Reciprocity, resilience and reliability are the three things I think I pride myself on most, along with a huge dose of enthusiasm for what I do. I love my job; it allows me to improve patient care, reduce the impact on the planet and every day I genuinely feel my contributions make a difference.


Sustainable Future with Clinical Procurement Nurses


We have an established network of fabulous clinical procurement colleagues across the NHS, including NHS England and Wales. As we see financial pressures grow and climate emergency worsen, I strongly believe that the Clinical Procurement Nurse is a critical invest-to-save role to save money, save patients and help save the planet.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Healthcare leaders are increasingly recognizing that procurement decisions influence far more than cost, shaping resilience, service delivery and long-term organizational performance. This perspective highlights why strategic procurement capabilities are becoming essential for balancing financial stewardship, operational continuity and patient-centered care in modern healthcare systems.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/cxoinsight/role-of-clinical-procurement-for-healthcare-s-resilient-future-nwid-2722.html